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ABSTRACT 
Although DNA microarray can detect multiple DNA samples simultaneously, current detection 
techniques involve PCR and other traditional procedures. In this study, a sensitive, specific and 
rapid detection method, which eliminates PCR and other lengthy processes, for pathogenic DNA 
is presented. This technology is based on the hybridization of target DNA to the immobilized 
probe, extension of probe DNAs using the target-DNA as a template and signal generation by 
streptavidin-horseradish peroxidase and substrate. This method is highly specific and sensitive, 
allowing single-nucleotide-base mismatches discrimination and the detection at femtomole level. 
The experiments are designed to achieve short hybridization time. Therefore, satisfactory signal 
can be detected within minutes, allowing the rapid detection of multiple pathogenic DNA. Most 
importantly, the E. coli genomic DNA can be detected using this technology. In conclusion, this 
detection method is useful for applications including on-site pathogenic disease detection, crime 
scene investigation, and pathogen inspection in the environment. 
INDEX WORDS: DNA microchip, DNA microarray, DNA chemiluminescent detection, 
Pathogenic DNA detection, Genomic DNA detection.
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 1 
1 INTRODUCTION 
1.1 DNA Microarray and Microchip Technology 
DNA microarray is a recent technology that allows the detection of multiple DNA samples as 
well as multiple pathogens from the same sample. 
1
Microarray technology has been advanced 
from radiolabeled, two- and three- dimensional and suspension bead microarrays, to qualitative 
and quantitative microarrays that produce gene expression and disease diagnostic results. 
1, 2
 
According to Miller et al., microarray technology and its use in detection of pathogenic diseases, 
has been growing vastly from the year 2000 to 2008. 
1
  
Microarray is a common and effective technique for the medical field as well as the scientific 
field because it allows the detection of pathogens, inspection of microorganism strains in the 
environment 
3
, diagnosis of diseases, discovery of genes 
4
and analysis of the single-nucleotide 
polymorphism(SNP). Genotyping of SNPs is important in disease studies. 
5
 Genetic disorders, 
pathogenic bacteria and infectious diseases can also be detected using DNA microarrays. 
6
  
Recently, there have been many flu outbreaks including swine flu, seasonal flu and avian 
influenza. 
7, 8
 This is due to the fact that diseases spread easily from one continent to the other, 
and it is necessary that detection must be done rapidly
9
 and the disease can be detected on-site to 
slow down the spreading. Furthermore, it is essential to have a detection method that selective, 
sensitive and cost-effective. 
9
 DNA microarray is a good method for these reasons. 
In a DNA microarray, certain concentration of DNA can be spotted manually or robotically. 
Generally, in a microarray experiment, RNA is extracted from a biological sample using certain 
buffers and reagents. This RNA is then copied as a cDNA using the reverse transcriptase, and 
normally, to multiply the DNA, polymerase chain reaction (PCR) is performed. 
9, 10
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To further carry out a microarray experiment, the double-stranded DNA (dsDNA) or synthesized 
long oligonucleotides with certain concentrations are printed on a microchip. The microchip 
serves as a solid support and is activated with chemical groups prior to the printing of the probes. 
The immobilization process of the probe to the chip occurs when the chip coated with certain 
chemicals react with what is labeled on the 5’ or 3’ end of the probe DNA. 
11, 12
 There are many 
steps involved in these DNA microarray experiments. Because many steps are required before 
the detection process, detection on-site with the collected samples, takes longer and less- 
efficient. 
1, 9, 13, 14
 In this study, a novel method for detection of pathogenic DNA using DNA 
chemiluminescent microarray is established. This method is not only efficient, rapid and cost-
effective, but also, it is simple, specific and sensitive.   
Today, there exist many types of DNA microarrays such as printed microarrays and electronic 
microarrays. Printed microarrays are relatively inexpensive and the glass chips are normally used 
in printed microarrays due to their stability, inexpensiveness and nonporous support. 
1
 In some 
studies, the microchips are three- dimensional microchannel, flow-thru chips and it was observed 
that the sensitivity is much higher compared to glass chips. 
11, 15, 16
 However, this study 
introduces DNA microarray using silicon microchips. Silicon microchips are easy to handle, 
strong, binds to the probes efficiently, inexpensive, stable at high temperatures, produce low 
background noise, and high signal intensity. 
11
 Thus, silicon microchips are useful in the DNA 
chemiluminescent detection. 
10, 17
 
Current pathogen detection using microarray is amplified using the polymerase chain reaction 
(PCR) 
1, 9, 13, 14
 and also, use either dsDNA or long single-stranded DNA (ssDNA) to immobilize 
on the chip. 
1
 This slows down the hybridization kinetics of the probe and the target DNA since 
the duplex probe DNA needs to be denatured first to bind to the target DNA. In this study, the 
 3 
 
probes do not need to be denatured or amplified. They bind efficiently to the silicon chip surface 
since the probes are modified at the 5’ end with an amino group. Also, the probes are short 
ssDNA and allow straightforward hybridization either with the single-stranded target DNA or the 
denatured, double-stranded target DNA.    
Another advantage of this DNA chemiluminescent microarray technology is, it eliminates the 
reverse transcription, PCR 
1, 9, 13, 14
 and transcription altogether. Some methods require extracting 
the mRNA from cells, and then, transforming the mRNA into cDNA to perform the detection. 
18, 
19
 The single-stranded probe DNA in this study is a short, synthesized oligonucleotide that can 
bind to the target DNA, which can be directly extracted from the bacterial culture or biological 
samples.  Moreover, because these probes are short, they also show a great selectivity. 
1, 3
 
In addition, this technology eliminates laser excitation fluorescent or radioactive labeling and gel 
electrophoresis. It only uses the chemiluminescent signal produced via the substrate catalyzed by 
horseradish peroxidase (HRP).  Moreover, in this method, antibodies are not needed unlike other 
detection methods. 
20
 Instead, biotinylated-dNTPs are used to bind to the target DNA via 
hydrogen bonding and Poly-HRP-streptavidin via non-covalent bonding.   
In conclusion, a novel method to detect pathogenic DNA, which eliminates lengthy procedures, 
and is sensitive and highly specific, will be established. In addition, it is also cost-effective and 
rapid. Thus, this method will make the disease detection much easier and will be useful for many 
other applications. 
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1.2 Basic Principles and Techniques 
1.2.1 Streptavidin-biotin Technology       
Streptavidin is a protein found in the bacterium Streptomyces avidinii and consists of 159 
residues. 
21
 These residues are folded to form four identical subunits known as tetramer. 
Each subunit is composed of a beta barrel formed by eight beta strands. 
22, 23
 All four of 
these subunits have identical biotin-binding sites with the same strong affinity for biotin. 
21-23
 Recently, many researchers have designed to block the three biotin-binding sites of 
streptavidin to have a specific binding to one site. This type of streptavidin is known as 
monovalent streptavidin.
23
 Some other modifications can also be done to the tetrameric 
protein to achieve more stability and durability in certain chemical environments. 
12, 23
      
Biotin is a vitamin known as vitamin H, and it also acts as a coenzyme or cofactor in 
many enzymatic and metabolic reactions including the citric cycle. Biotin is also water-
soluble. 
12, 24, 25
 As shown in Figure 1, biotin has a valeric side chain, which is useful in 
linking with other molecules. Since biotin is a small molecule, for some application, it is 
convenient to link it with different molecules including proteins and nucleotides. When a 
biotin is linked with another molecule, the process is called biotinylation. 
Oligonucleotides are well known to link with biotin. In this study, different biotinylated-
dNTPs will be used to show the selectivity in the DNA microchip detection. In other 
words, all types of biotinylated-dNTPs can be used in the detection of pathogenic DNA. 
12, 24, 25
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Figure 1: Chemical structure of biotin. 
 
Streptavidin can bind biotin strongly though a non-covalent bond. This strong non-
covalent binding between biotin and streptavidin has a dissociation constant of 
approximately 10
-15 
M. 
12, 24-26
  In this study, taking advantage of this streptavidin-biotin 
technology, and availability of biotinylated-dNTPs, the DNA chemiluminescent detection 
is carried out.  
     
1.2.2 SuperSignal ELISA Femto Maximum Sensitivity Substrate 
The SuperSignal ELISA Femto Maximum Sensitivity Substrate is a sensitive substrate 
that uses the horseradish peroxidase as a catalyst to produce energy in the form of light. 
This substrate is highly sensitive. In addition, the amount of time it takes for the substrate 
to reach its maximum sensitivity is only 1 min.   
The SuperSignal ELISA Femto Maximum Sensitivity Substrate includes two 
components. These two components are luminol enhancer solution and stable peroxide 
solution. These two solutions are used in equal amounts in this study to detect the signal 
produced in the form of chemiluminescent light. For detection of the chemiluminescent 
signal, a microscope with a CCD camera is used. 
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1.3 Current Methods of Pathogen Detection   
In recent years, rapid detection of pathogens becomes essential. As the transportation systems are 
enhanced, the diseases are spread easily through carriers and contacts. Although a disease 
outbreak can occur in North America, it can spread to other continents in hours. Thus, it is 
necessary to detect pathogens on-site to prevent the disease from spreading at a high speed. By 
doing so, the spread of disease can be contained better. In addition to the need for on-site 
detection, it is essential to rapidly detect the diseases even in clinics and hospitals.  
One of the disease detection methods currently available is to perform biochemical tests. Tests, 
such as the MacConkey agar test that detects the presence of E. coli, take a long time due to 
overnight incubation and so forth. 
27, 28
 There are many types of E. coli strains, 
29
 and some E. 
coli strains are more dangerous than others. E. coli can be present as normal flora; however, E. 
coli is very dangerous when present in the urinary or gastrointestinal tracts and can cause 
infections including urinary tract infections in humans. Recently, E. coli has become the food 
borne pathogen 
30
 and many people are ill from eating infected food. Thus, the methods to detect 
such types of bacteria must be effective and rapid to eliminate unnecessary illnesses.  
Another technique that is available for disease detection uses microarray technology and 
polymerase chain reaction. This method requires extraction of mRNA from the tissue sample, 
reverse transcription of extracted mRNA into cDNA, and polymerase chain reaction (PCR) to 
multiply the cDNA obtained. 
1, 9, 13, 14, 19
 PCR is a useful amplification method to multiply the 
cDNA copies obtained from the reverse transcription. 
1, 9, 13, 14
 According to Nam et al., 
polymerase chain reaction normally requires many steps, takes a long time, and is expensive and 
difficult to perform. 
31
  In other words, PCR involves repeated steps of denaturation, 
hybridization, and elongation of the DNA. 
1, 9, 13, 14
 These steps take a long time and contain 
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lengthy procedures. Thus, it is necessary to establish a simple and effective procedure to detect 
pathogenic DNA. Also, the procedure should have a great sensitivity and specificity.   
    
1.4 Objective of This Study         
Recently available techniques either contain complicated procedures or are not sensitive and 
specific enough in detection. Thus, the objective of this study is to establish a DNA detection 
method that is simple, rapid, sensitive and specific using the DNA microchip and microarray 
technology. This detection method will be useful for medical field as well as on-site detection of 
pathogenic diseases. This study will focus mainly on the detection of synthesized DNA and 
genomic DNA. In addition, detection sensitivity and specificity will also be studied.  
For this study, the probe DNA will be synthesized, printed on the silicon-coated microchip and 
used as a primer. The complementary target DNA will then bind to this primer via hybridization 
at a high temperature. This target DNA is longer in sequence, and therefore, biotin-labeled 
dNTPs can, in turn, bind to the extra nucleotides on the target DNA using the Klenow Fragment 
of DNA polymerase I. Klenow Fragment is a large fragment with a molecular weight of 
approximately 68 kDa. 
32, 33
 This fragment is a result of proteolysis of DNA polymerase I. It 
mainly performs two activities. These activities include DNA polymerase activity and 3’ to 5’ 
exonuclease activity. The 3’ to 5’ exonuclease activity proofreads the newly synthesized DNA 
strand and removes mismatched nucleotides. In this experiment, the Klenow Fragment helps 
extend the probe DNA that is immobilized on the chip using the target DNA as a template. 
32, 33
 
Poly-HRP-streptavidin will then bind to biotin forming a streptavidin-biotin complex, and 
proceed through the oxidation-reduction reaction when the SuperSignal ELISA Maximum Femto 
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Sensitivity Substrate is added. Luminol is oxidized and the chemiluminescent signal that is given 
out is detected using the microscope with a CCD camera.  
 9 
 
2 MATERIALS AND METHODS 
2.1 Oligonucleotides 
Original lacZ mRNA [lacZ, E. coli lacZ mRNA: 724-747 nt]:    
5’-AUGUGGAUUGGCGAUAAAAAACAA-3’ 
Synthesized lacZ E. coli target DNA (24mer-1): 5’-ATGTGGATTGGCGATAAAAAACAA-3’ 
Synthesized lacZ E. coli probe DNA (15mer): 5’-NH2-TTGTTTTTTATCGCC-3’ 
 
Original 23S rRNA E. coli [rrlA, E. coli str. K-12 substr. MG 1655, 23S ribosomal RNA of rrnA 
operon : 483-508 nt] : 5’-ACCCCGGCGAGGGGAGTGAAAAAGAA-3’ 
Synthesized 23S rRNA E. coli Chimeric Probe (26mer-P): 5’-d(TTCTTTTT)-2’-O-
Me(CACTCCCCTC)-d(GCCGGGGT) -NH2-3’  
 
Bird flu DNA-RNA-DNA Chimeric Probe:  
5’-d(TCGTTTTT)-2’-O-Me(GGUAGGUCUGCAAAAUUUU)-d(CAAGAAGATT)-NH2-3’ 
 
Original Sample 1 RNA: 5’-AGAUCGCGCAGAGACUGGAAAGUGU-3’  
Synthesized Sample 1 Target DNA (S1-T): 5’-AGATCGCGCAGAGACTGGAAAGTGT-3’ 
Synthesized Sample 1 Probe DNA (S1-P): 5’-NH2- ACACTTTCCAGTCTC-3  
 
Original Sample 2 RNA: 5’-AAUCUUCUUGAAAAUUUGCAGACCUACCAAAAACGA-3’ 
Synthesized Sample 2 Target DNA (S2-T):  
5’-AATCTTCTTGAAAATTTGCAGACCTACCAAAAACGA-3’ 
Synthesized Sample 2 Probe DNA (S2-P): 5’-NH2- TCGTTTTTGGTAGGTCT-3’ 
 10 
 
Original Bacillus anthraces RNA [BA, B. anthraces lethal factor mRNA: 855-891 nt]:  
5’-AUCUUUAGAAGCAUUAUCUGAAGAUAAGAAAAAAA-3’ 
Bacillus anthraces Target DNA (BA-T):   
5’-ATCTTTAGAAGCATTATCTGAAGATAAGAAAAAAA-3’ 
Bacillus anthraces Probe DNA (BA-P): 5’-NH2- TTTTTTTCTTATCTT-3’ 
 
Mismatched 24mer sequences of lacZ E. coli target DNA for Specificity Study:  
24mer-1: 5’-ATGTGGATTGGCGATAAAAAACAA-3’ 
24mer-2: 5’-ATGTGGATTCGCGATAAAAAACAA-3’ 
24mer-3: 5’-ATGTGGATTGACGATAAAAAACAA-3’ 
24mer-4: 5’-ATGTGGATTGGGGATAAAAAACAA-3’ 
24mer-5: 5’-ATGTGGATTGGCGACAAAAAACAA-3’ 
24mer-6: 5’-ATGTGGATTGGCGATAAATAACAA-3’ 
24mer-7: 5’-ATGTGGATTGGGGACAAAAAACAA-3’ 
24mer-8: 5’-ATGTGGATTGGGGATAAATAACAA-3’ 
 
DNA for hybridization kinetics study (Biotin-24mer-1):  
5’-biotin-ATGTGGATTGGCGATAAAAAACAA-3’ 
 
 
 
 
 
 
 
 
 
 
 11 
 
2.2 Other Materials 
2.2.1 Reagents and DNA Samples 
• Escherichia coli K-12 strain genomic DNA: 10 µg/ µL 
• DNA Polymerase I Klenow: 5000 u mL
-1
 (New England Biolabs, Ipswich, MA)  
• Biotinylated- dNTPs: 0.4 mM (Invitrogen, Eugene, OR and Perkin Elmer, Waltham, 
MA) 
• Poly-HRP Streptavidin: 1.0 mg/ mL (Thermo Fisher Scientific, Rockford, IL) 
• 3- aminopropyltrimethoxysilane (Aldrich, St. Louis, MO) 
• 1,4-phenylene diisothiocyanate: 10 mM (PDITC, Fluka, Buchs, Switzerland) 
 
2.2.2 Buffers 
• 5x concentrated sodium chloride and sodium citrate buffer (5x SSC): 3.0 M NaCl, 3.0 
M sodium citrate, pH 7.0 
• 1x concentrated phosphate buffered saline buffer (1x PBS): NaCl, KCl, Na2HPO4, 
KH2PO4, pH 7.4 
• Sodium Phosphate Buffer: 100 mM, pH 7.5 
• Starting Block (TBS) Blocking Buffer: Protein based blocker formulation in tris 
buffered saline (Thermo Fisher Scientific, Rockford, IL) 
• Large Klenow Fragment Buffer (NE Buffer 2): 1x concentrated ( New England 
Biolabs, Ipswich, MA)  
• Blocking Buffer: 10 mg/ mL (component D of  Tyramide Signal Amplification (TSA) 
Kit # 21 dissolved in 1x PBS buffer) 
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2.2.3 Kits 
• Supersignal Enzyme-linked immunosorbent assay (ELISA) Femto Maximum 
Sensitivity Substrate (Thermo Fisher Scientific, Rockford, IL) 
o Luminol/Enhancer Solution 
o Stable Peroxide Solution 
• Tyramide Signal Amplification (TSA) Kit # 21 ( Invitrogen, Eugene, OR) 
o Component A: biotin- XX tyramide 
o Component B: Dimethylsulfoxide (DMS0) 
o Component C: HRP-conjugated secondary antibody or Streptavidin 
o Component D: Blocking reagent 
o Component E: Amplification buffer 
o Component F: Hydrogen Peroxide  
 
2.2.4 Instruments 
• Omni Grid Micro (Genomic Solutions) 
• Microscope (Nikon 80i) 
• Charged coupled device (CCD) camera (VersArray, Princeton Instruments, Inc.)  
• Waterbath Model 1202 (VWR Scientific Products) 
• Heating block 
 
2.3 Oligonucleotides Synthesis, Deprotection and Precipitation 
Oligonucleotides were synthesized on the Applied BioSystems 3400 DNA synthesizer at 1 µM 
scale. The probes were modified with an amino group at the 5’ end to easily immobilize on the 
silicon chip. On the other hand, for the hybridization kinetic study, the target DNA (24mer-1) 
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was modified with biotin on the 5’ end during the synthesis. For the other targets, there was no 
modification during the synthesis. After the synthesis, all oligonucleotides were de-protected by 
aqueous ammonium hydroxide treatment and desalted by ethanol precipitation. The purity was 
checked, and the samples were quantified using an UV-Vis spectrophotometer.  
 
2.4 Microchip Activation  
To activate the silicon chips (0.5 × 0.5 cm), the chips were placed in the incubation chamber and 
treated with methylene chloride (CH2Cl2) for 15 min on the shaker at 100 RPM. The chips were 
then air-dried at room temperature (RT), and were immersed in a solution containing 19:1 
ethanol to RNase-free water with 3% 3- aminopropyltrimethoxysilane (Aldrich, St. Louis, MO). 
Then, the chamber was left on the shaker for 45 min at 100 RPM at RT. Subsequently, the chips 
were rinsed with ethanol, RNase-free water, and once again with ethanol. After air-drying the 
chips, they were immersed in the solution containing 10 mM 1,4-phenylene diisothiocyanate 
(PDITC, Fluka, Buchs, Switzerland), CH2Cl2, and 1% pyridine. The chamber was then again 
placed on the shaker for 2 hr at 100 RPM at RT and rinsed three times with methylene chloride. 
Then, the chips were air-dried and were stored at RT in the argon atmosphere. Shown in Figure 2 
are the steps involving in the activation of the silicon microchip. 
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Figure 2: Microchip activation and probe immobilization. 
 
 
2.5 Probe Immobilization 
The probe DNA was diluted in 100 mM sodium phosphate (pH 7.5) to obtain a concentration of 
250 µM. This probe DNA was then printed on the activated silicon microchip (0.5 × 0.5 cm) 
using the OmniGrid Micro. Each spot size is approximately 75 micron. Subsequently, the chip 
was incubated at 37- 40° C for 30 min. 
 
2.6 Target Hybridization 
2.6.1 Detection Using the Synthesized lacZ E. coli Target DNA 
After the probe DNA (250 µM, 15 mer) was immobilized on the chip (15 × 15 spots), a 
solution containing 24mer-1 (2-500 fmol) with 5XSSC buffer (19 µL, 3.0 M NaCl, 3.0 M 
sodium citrate, pH 7.0) was applied on the chip. The chip was incubated for 15 min at 40- 
42° C in a water bath. Subsequently, the chip was rinsed with hot 1XPBS (100 µL) buffer 
three times to remove the unbounded DNA.  
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2.6.2 Detection of the E. coli Genomic Target DNA  
After the probe DNA (250 µM, 15 mer) was fixed on the chip (15 × 15 spots), the 
solution containing E. coli genomic target DNA sample (5- 10 µg) and 5XSSC buffer (4 
µL, 3.0 M NaCl, 3.0 M sodium citrate, pH 7.0), which was denatured at 95° C for 2 min, 
and cooled in ice for 30- 60 sec, was applied on the chip. The chip was incubated for 15 
min at 45- 50° C in a water bath. Subsequently, the chip was rinsed three times with hot 
1XPBS (100 µL) buffer to remove the unbounded DNA. As a positive control, 24mer-1 
(10 fmol) was used as a target DNA, and as a negative control, RNase-free water was 
used as a target DNA.  
 
2.6.3 Specificity in DNA Detection: Mismatched Target DNA Sequences 
After the probe DNA (250 µM, 15 mer) was fixed on the chip (15 × 15 spots), the chip 
was divided into sections using parafilm. Then, different 24mer, mismatched-sequence 
samples (50 fmol) were applied on the chip for 15 min at 40- 42° C. The chip was rinsed 
with 100 µL of hot 1X PBS buffer three times.  
   
2.6.4 Specificity in DNA Detection: Different DNA Probes Sequences 
The activated microchip was fixed (10 × 2 spots) with four different DNA probes: 
5XSSC buffer, Bird flu DNA-RNA-DNA chimeric probe (250 µM), 26mer-P (250 µM), 
and 15mer (250 µM). Subsequently, 24mer-1 (5 fmol) with 5XSSC buffer (19 µL, 3.0 M 
NaCl, 3.0 M sodium citrate, pH 7.0) was applied on the chips for 15 min at 40- 42° C. 
Then, the chip was rinsed with 100 µL of hot 1X PBS buffer three times.  
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2.6.5 Sensitivity in DNA Detection: 15mer with 24mer-1 
After the probe DNA (250 µM 15 mer) was fixed on the chip (15 × 15 spots), the chip 
was divided into sections using parafilm. Then, different absolute quantities of 24mer-1 
(2- 50 fmol) with 5XSSC buffer (2-3 µL, 3.0 M NaCl, 3.0 M sodium citrate, pH 7.0), 
were applied to designated sections on the chips for 15 min at 40- 42° C. The chip was 
rinsed three times with hot 1X PBS buffer (100 µL).    
  
2.6.6 Combination of Specificity and Sensitivity Detection  
The activated microchip was fixed (10 × 2 spots) with four probe samples: 5XSSC 
buffer, Bird flu DNA-RNA-DNA chimeric probe (250 µM), 26mer-P (250 µM), and 
15mer (250 µM). Subsequently, 24mer-1 (2 fmol) with 5XSSC buffer (19 µL, 3.0 M 
NaCl, 3.0 M sodium citrate, pH 7.0), was applied on the chip for 15 min at 37- 40° C. 
The chip was rinsed three times with hot 1X PBS buffer (100 µL).   
  
2.6.7 E. coli Genomic Target DNA Doped with Synthesized Target DNA 
After the probe DNA (250 µM, 15 mer) was fixed on the chip (15 × 15 spots), the chip 
was divided into sections using parafilm. In the first section, 24mer-1 (2-10 fmol) doped 
with E. coli genomic target DNA (0.5 µg) was applied. In the second section, only E. coli 
genomic target DNA (0.5 µg) was applied. In the third section, only RNase-free water 
was applied. In the fourth section, only 24mer-1 (2-10 fmol) was applied. These target 
DNA samples were allowed to hybridize for 15 min at 40- 42° C. The chip was rinsed 
three times with hot 1X PBS buffer (100 µL).   
 
 17 
 
2.7 Klenow Extension, Biotin-labeling, and Chemiluminescent Detection  
After the probe is immobilized on the chip and hybridized with the target DNA, the Klenow 
Fragment of DNA polymerase I helps extend the probe DNA with biotin-labeled dNTPs using 
the target DNA as a template. In other words, after the hybridization step, the chip was incubated 
with Klenow buffer (2 µL, 1 X, New England Biolabs, Ipswich, MA), the Klenow fragment (0.5 
µL, 5000 u mL
-1
, New England Biolabs, Ipswich, MA), RNase-free water (16.5 µL) and biotin-
14-dATP (1 µL, 0.4 mM Invitrogen, Eugene, OR) for 30 min at 37- 40° C. Then, the chip was 
rinsed three times with 1XPBS buffer to remove the unbounded biotin-14-dATP. Then, the 
solution containing HRP-conjugated Streptavidin (1 µL, component C, Invitrogen, Eugene, OR) 
and the blocking reagent (10 mg/ mL, component D in 1XPBS, Invitrogen, Eugene, OR) was 
applied on the chip. The chip was then incubated for 30 min at 37- 40° C, and was washed with 
1XPBS buffer 3 times. Subsequently, the hydrogen peroxide (0.25 µL, component F, Invitrogen, 
Eugene, OR) and amplification buffer (50 µL, component E, 0.02% thimerosal, Invitrogen, 
Eugene, OR), were mixed and 1 µL of that solution is added to a mixture of amplification buffer 
(100 µL, component E, 0.02% thimerosal, Invitrogen, Eugene, OR) and biotin-XX-tyramide (1 
µL, component A, Invitrogen, Eugene, OR). Then, this resulted solution was applied on the chip 
for 5 min at RT, and washed with 1XPBS buffer three times. Afterwards, Poly-HRP streptavidin 
(0.25 µL, Thermo Fisher Scientific, Rockford, IL) and StartingBlock (TBS) Blocking Buffer 
(1000 µL, Thermo Fisher Scientific, Rockford, IL) were applied on the chip for 15 min at RT. 
The chips were then rinsed with 1X PBS buffer 5 times, and placed in 1:1 luminol/ enhancer to 
stable peroxide solutions of Super Signal ELISA Femto Maximum Sensitivity Substrate (Thermo 
Fisher Scientific, Rockford, IL). Then, the chemiluminescent signal was immediately detected 
using a microscope with a charged coupled device (CCD). 
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2.8 DNA Hybridization Kinetics 
After the probe DNA (250 µM, 15 mer) was fixed on the chip (15 × 15 spots), the chip was 
divided into sections using parafilm. Then, Biotin-24mer-1 (50- 500 fmol) with 5XSSC buffer (2 
µL, 3.0 M NaCl, 3.0 M sodium citrate, pH 7.0), was applied on the chip, and incubated at 40° C 
for various hybridization timings: 40, 30, 20, 15, 10, 5, 3, 2, 1 and 0 min. The chip was rinsed 
with 100 µL of hot 1X PBS buffer three times. Because the target DNA is already modified with 
biotin, polymerization using the Klenow Fragment was eliminated. Then, the solution containing 
HRP-conjugated Streptavidin (1 µL component C, Invitrogen, Eugene, OR) and the blocking 
reagent (10 mg/ mL, component D in 1XPBS, Invitrogen, Eugene, OR) was applied on the chip. 
The chip was then incubated for 30 min at 37- 40° C, and was washed with 1XPBS buffer 3 
times. Subsequently, the hydrogen peroxide (0.25 µL, component F, Invitrogen, Eugene, OR) 
and amplification buffer (50 µL, component E, 0.02% thimerosal, Invitrogen, Eugene, OR), were 
mixed and 1 µL of that solution is added to a mixture of amplification buffer (100 µL, 
component E, 0.02% thimerosal, Invitrogen, Eugene, OR) and biotin-XX-tyramide (1 µL, 
component A, Invitrogen, Eugene, OR). Then, this resulted solution was applied on the chip for 
5 min at RT, and washed with 1XPBS buffer three times. Afterwards, Poly-HRP Streptavidin 
(0.25 µL, Thermo Fisher Scientific, Rockford, IL) and StartingBlock (TBS) Blocking Buffer 
(1000 µL, Thermo Fisher Scientific, Rockford, IL) were applied on the chip for 15 min at RT. 
The chips were then rinsed with 1X PBS buffer 5 times, and placed in 1:1 luminol/ enhancer to 
stable peroxide solutions of Super Signal ELISA Femto Maximum Sensitivity Substrate (Thermo 
Fisher Scientific, Rockford, IL). Then, the chemiluminescent signal was observed using a 
charged coupled device camera (CCD camera). 
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2.9 Multiple Pathogenic DNA Detection  
Four different probes were printed on the chip (250 µM 10 × 2 spots each) in this order: BA-P, 
S1-P, S2-P and 15 mer.  These probes were then immobilized on the chip for 30 min at 40° C. 
Then, one, two or three targets (50- 5pmol) were applied on the chips to hybridize with their 
specific probe DNA for 15 min at 45° C. The chip was then rinsed three times with 100 µL of 
hot 1X PBS buffer. After the hybridization step, the chip was incubated with Klenow buffer (2 
µL, 1 X, New England Biolabs, Ipswich, MA), the Klenow fragment (0.5 µL, 5000 u mL
-1
, New 
England Biolabs, Ipswich, MA), RNase-free water (13.5 µL) and biotin-14-dATP (1 µL, 0.4 
mM, Invitrogen, Eugene, OR), biotin-14-dCTP (1 µL, 0.4 mM, Perkin Elmer, Waltham, MA), 
biotin-11-dGTP (1 µL, 0.4 mM Invitrogen, Eugene, OR), and biotin-11-dUTP (1 µL, 0.4 mM, 
Perkin Elmer, Waltham, MA), for 30 min at 37- 40° C. Then, the chip was rinsed three times 
with 1XPBS buffer to remove the unbounded biotin-14-dATP. Then, the solution containing 
HRP-conjugated Streptavidin (1 µL, component C, Invitrogen, Eugene, OR) and the blocking 
reagent (10 mg/ mL, component D in 1XPBS, Invitrogen, Eugene, OR) was applied on the chip. 
The chip was then incubated for 30 min at 37-40° C, and was washed with 1XPBS buffer 3 
times. Subsequently, the hydrogen peroxide (0.25 µL, component F, Invitrogen, Eugene, OR) 
and amplification buffer (50 µL, component E, 0.02% thimerosal, Invitrogen, Eugene, OR), were 
mixed and 1 µL of that solution is added to a mixture of amplification buffer (100 µL, 
component E, 0.02% thimerosal, Invitrogen, Eugene, OR) and biotin-XX-tyramide (1 µL, 
component A, Invitrogen, Eugene, OR). Then, this resulted solution was applied on the chip for 
5 min at RT, and washed with 1XPBS buffer three times. Afterwards, Poly-HRP Streptavidin 
(0.25 µL, Thermo Fisher Scientific, Rockford, IL) and StartingBlock (TBS) Blocking Buffer 
(1000 µL, Thermo Fisher Scientific, Rockford, IL) were applied on the chip for 15 min at RT. 
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The chips were then rinsed with 1X PBS buffer 5 times, and placed in 1:1 luminol/ enhancer to 
stable peroxide solutions of Super Signal ELISA Femto Maximum Sensitivity Substrate (Thermo 
Fisher Scientific, Rockford, IL). Then, the chemiluminescent signal was observed using a 
charged coupled device camera (CCD camera). 
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3 DNA CHEMILUMINESCENCE DETECTION  
3.1 Overview of DNA Detection  
In this study, the 5’-amino-modified lacZ E. coli DNA (15mer) is synthesized and printed on the 
activated silicon surface. This probe DNA (15mer) is complementary to the target DNA (24mer-
1) and hybridizes with 24mer-1 at a high temperature. After the hybridization, the Large Klenow 
Fragment of DNA polymerase I of Escherichia coli incorporates the biotin-labeled dNTPs using 
the target DNA as a template. In other words, this process extends the probe DNA (15mer). 
Poly-HRP streptavidin then binds to the labeled biotin, forming a streptavidin-biotin complex, 
and proceeds through the oxidation-reduction reaction when combined with the SuperSignal 
ELISA Maximum Femto Sensitivity Substrate. The chemiluminescent signal that is given out 
from this reaction is detected using a microscope with a charge coupled device (CCD).  
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Figure 3: DNA chemiluminescent detection overview. Image A: Immobilization of DNA probes; 
Image B: Hybridization of the target DNA to the immobilized probes; Image C: Klenow 
extension using biotin-14-dATP; Image D: Poly-HRP-streptavidin binding to biotin and substrate 
to produce energy in a form of light; Image E: Virtual image of signal production overview; 
Image F: Detection using a microscope and CCD camera; Image G: Computer-generated, 
detectable chemiluminescent signal. 
 
 
Shown in Figure 3 is an overview of the DNA chemiluminescent detection. In Image A, virtual 
image of the printed oligonucleotides are shown. Also, shown in Image A is the detail pictorial 
presentation of the immobilization of the probe DNA to the chip surface. In Image B, the 
hybridization of target DNA to the immobilized probes is shown. In Image C, the incorporation 
of the biotinylated-dATP by the Klenow Fragment using the target DNA as a template is shown. 
In Image D and E, the binding of Poly-HRP streptavidin to biotin and substrate are shown as 
well as the chemiluminescent signal that is given off when luminol is oxidized during the 
reaction with hydrogen peroxide (H2O2). This reaction is catalyzed by horseradish peroxidase 
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(HRP). The energy in the form of light is produced and the chemiluminescent signal is then 
detected using a microscope with a charge coupled device (CCD) as shown in Image F. Shown 
in Image G is a virtual presentation of the computer-generated result.  
   
3.2 Processes Involved in DNA Detection 
3.2.1 Microchip Activation 
Activation of the silicon chip surface is necessary in order to immobilize the probe DNA 
on the silicon surface. In this study, the activation of chip is done by silylation, amino-
functionalization and treatment with 1,4-phenylene diisothiocyanate (PDITC). PDITC is 
a bifunctional linker. In other words, it binds covalently to the amino groups from 8-
Aminopyrene-1,3,6-trisulfonic acid, trisodium salt (APTS) and the probe DNA. To 
activate the microchips, the chips must be cleaned and their surfaces must be free of dust 
and oil. Therefore, to degrease and remove dust from the surface, the silicon-coated 
microchips are washed several times. These cleaned microchips then undergo silylation 
and amino-functionalization. Then, the chip is activated using the PDITC and it provides 
support for the oligonucleotides modified with an amino group at the 5’end.  
 
3.2.2 Immobilization of DNA Probes 
The amino group on the 5’ end of the probe DNA is attached to the activated silicon 
surface. This step requires the chip to be incubated at 37° C for 30 min. Once the probe 
DNA is immobilized on the chip, it is ready to undergo hybridization with the target 
DNA.  Shown in Figure 4 is the immobilized probe on the activated microchip.  
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Figure 4: Probe immobilization on the activated silicon surface. 
 
3.2.3 Target Hybridization 
When the probe DNA is immobilized on the chip, the complementary DNA is applied on 
the chip to hybridize with the probe DNA. In this experiment, 15mer is the probe DNA 
and 24mer-1 is complementary to 15mer. This 24mer-1 is a single-stranded DNA 
(ssDNA), and therefore, it does not require denaturing. However, it is better to hybridize 
the two DNA stands at an optimum temperature because at a high temperature, the 
enzymes as well as the duplex DNA will denature whereas at a low temperature, non-
specific binding increases the background noise. If the target DNA that will undergo 
hybridization with the probe DNA is a dsDNA, then first, it must be denatured and must 
be hybridized immediately with the probe DNA before the two stands of the duplex DNA 
hybridize again.  
 
3.2.4 Klenow Extension, Biotin- labeling, TSA Amplification and Detection  
After the target DNA hybridizes with the probe DNA, in order to have the biotinylated-
dNTPs bind to the extended region of target DNA, the Large Klenow Fragment of DNA 
polymerase I must create a bond between the last nucleotide of the probe DNA and the 
biotinylated-dNTPs.  
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Figure 5: The virtual microchip surface during the DNA chemiluminescent detection. 
 
Poly-HRP-streptavidin then binds to the available biotin from the biotinylated-dATP. The 
signal is further amplified using the tyramide signal amplification (TSA) kit. At the last 
step, the substrate is added to produce chemiluminescent signal. This signal is then 
detected using a microscope with a charge coupled device (CCD). Shown in Figure 5 is 
the virtual illustration of the microchip during the detection.  
A B
 
Figure 6: The virtual microchip with immobilized DNA probes (Image A), and the virtual 
microchip when the chemiluminescent signal is detected (Image B). 
 
In addition, in Figure 6, the chip before and after the generation of signal, is illustrated. 
These images are only the virtual illustrations to show a model image of how the chip 
appears as a computer-generated result.  
Thus, this method is a simple and efficient method to detect pathogenic DNA, and it 
eliminates lengthy procedures including PCR, radioactive labeling and so forth. 
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4 SPECIFICITY IN DNA DETECTION  
4.1 Introduction 
One of the requirements for any pathogenic DNA detection method is to be able to detect 
specifically the pathogenic sample from multiple samples. In other words, the detection method 
must show a good specificity. To analyze this factor, the specificity experiments are designed.  
 In the specificity experiments, various probes are printed on the chip to analyze how the target 
DNA can specifically bind to the proper probe DNA. Another type of specificity experiments is 
also designed so that the detection is not only specific to the correct probe, but also specific to 
the detail in the probe sequences. In other words, single-base mismatch discrimination should be 
observed. To apply this concept, several target DNA, varied in sequences by one or two 
nucleotides, are designed (24mer-2 to 24mer-8). It is expected that the probe DNA will bind 
specifically to the target DNA with the perfect match. In addition, to show the specificity using 
different samples, multiple pathogens will be designed and detected using the chemiluminescent 
detection. In other words, the experiments should provide support that this detection method 
allows differentiation between various pathogenic DNA samples.  
 
4.2 Results 
4.2.1 Specificity in Detection: Four Different Probes  
In this experiment, four different probes were spotted on the activated silicon surface. 
These probes include 5XSSC buffer, Bird flu DNA-RNA-DNA chimeric probe, 26mer-P, 
and 15mer. Then, 24mer-1 (5 fmol) was applied on the chip to observe whether it binds 
specifically to 15mer discriminating the other probes. Based on the results obtained, 
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24mer-1 binds only to 15mer and did not bind to other probes that were immobilized on 
the chip. In other words, the results show a great specificity of 24mer-1 to 15mer. 
 
Figure 7: The specificity of 24mer-1 (5 fmol) to 15mer.  Image 1: 5XSSC buffer; Image 
2: 15mer; Image 3: DNA-RNA-DNA chimeric probe of rRNA E. coli (26mer-P), Image 
4: Bird flu DNA-RNA-DNA chimeric probe. (Detection conditions: 5 sec exposure, 2×2 
binning, 2X lens) 
 
 
4.2.2 Specificity in Detection: Mismatched Sequences of 24mer-1 
In this experiment, the probe DNA (15mer) was spotted (15× 15 spots) on the chip and 
different sequences of the target DNA (24mer-1) were applied on different sections of the 
chip. These mismatched-sequences of 24mer-1 differ in that each has one or two 
mismatched nucleotides. As shown in Figure 8, the results showed that 15mer binds 
specifically to 24mer-1, which is its perfect match.  
 
Figure 8: The specificity of probe DNA (15mer) to the target DNA (mismatched 
sequences of 24mer, 50 fmol). Image 1A, 1B, and 1C: 24mer-1; Image 2: 24mer-2; 
Image 3: 24mer-3; Image 4: 24mer-4; Image 5: 24mer-5; Image 6: 24mer-6; Image 7: 
24mer-7; Image 8: 24mer-8. (Detection conditions: 5 sec exposure, 2×2 binning, 2X lens) 
4.2.3 Specificity in Detection: Multiple Pathogenic DNA Detection 
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15mer:  5’-NH2-TTGTTTTTTATCGCC-3’ 
 
24mer-1:5’-ATGTGGATTGGCGATAAAAAACAA-3’ 
24mer-2:5’-ATGTGGATTCGCGATAAAAAACAA-3’ 
24mer-3:5’-ATGTGGATTGACGATAAAAAACAA-3’ 
24mer-4:5’-ATGTGGATTGGGGATAAAAAACAA-3’ 
24mer-5:5’-ATGTGGATTGGCGACAAAAAACAA-3’ 
24mer-6:5’-ATGTGGATTGGCGATAAATAACAA-3’ 
24mer-7:5’-ATGTGGATTGGGGACAAAAAACAA-3’ 
24mer-8:5’-ATGTGGATTGGGGATAAATAACAA-3’ 
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To observe whether the chemiluminescent DNA detection method shows specificity 
between different pathogens, four probes (Bacillus anthraces, Sample 1, Sample 2, and 
15mer) were printed on the chip and one or more target DNA (50- 5 pmol) was applied 
on the chip. The results obtained from using 5 pmol of each target DNA, are shown in 
Figure 9. Although there was some background noise, it was mainly due to the chip 
contamination. According to the results from the multiple pathogen detection, the DNA 
chemiluminescent detection is highly specific. It can discriminate between different 
pathogenic DNA.  
 
 
Figure 9: Multiple Pathogen Detection. Four different probes DNA were spotted on the 
chips (from top down): Bacillus anthraces (BA-P), Sample 1 (S1-P), Sample 2 (S2-P), 
and 15mer. Then, target DNA (5 pmol) is applied to observe specificity. Image A: 
Bacillus anthraces target DNA (BA-T); Image B: Sample 1 target DNA (S1-T); Image C: 
24mer-1; Image D: Bacillus anthraces target DNA (BA-T) and Sample 2 target DNA 
(S2-T); Image E: Sample 1 target DNA (S1-T) and 24mer-1; Image F: Bacillus anthraces 
target DNA (BA-T), Sample 1 target DNA (S1-T) and 24mer-1. (Detection conditions: 5 
sec exposure, 2×2 binning, 2X lens) 
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4.3 Conclusion 
Based on the results obtained, it was observed that 24mer-1 and 15mer recognized each other 
well in the presence of other probes. In addition, 15mer can also discriminate between the 
mismatch sequences and the perfect match (24mer-1). Moreover, other probes and targets from 
different pathogens can also recognize each other, discriminating the non-specific pathogens, and 
allowing only the specific probes and targets to hybridize. This makes the multiple pathogenic 
DNA detection using the DNA microchip technology, highly specific. In conclusion, this DNA 
detection method shows a great specificity in detection not only for lacZ gene of E. coli, but also 
for other pathogenic DNA as well.  
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5 SENSITIVITY IN DNA DETECTION  
5.1 Introduction 
Detection of pathogenic DNA on the microchip is indeed useful for clinical studies as well as on-
site detection. However, at times, the concentrations of the samples that are obtained on-site may 
be low. Thus, it is extremely important that the signal can be detected at low concentrations. To 
study sensitivity in DNA detection, the detection limit must be determined. The experiments are 
designed so that even when samples with a low concentration are supplied, the detection can be 
done. In other words, in these experiments, different absolute quantities of target DNA are used 
to observe the detection limit. Moreover, it is also necessary to detect different samples at low 
concentration. Thus, some experiments are designed to differentiate between samples at the 
detection limit.  
 
5.2 Results 
5.2.1 Detection Limit of the Synthesized E. coli Target DNA 
In this experiment, 24mer-1, which is the synthesized lacZ E. coli target DNA, was 
hybridized with the probe DNA (15mer) at different absolute quantities. Shown in Figure 
10 are the results of the synthesized target DNA detection. Image 1 through 8 represents 
the results obtained from using different absolute quantities of target DNA (24mer-1). At 
the absolute quantity of 5 pmol, the signal was very strong. However, as the absolute 
quantity decreased, the signal became weaker. The detection limit was observed to be 2 
fmol.  
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Figure 10: Synthesized target DNA detection at different absolute quantities. Image 1: 5 
pmol; Image 2: 50 fmol; Image 3: 10 fmol; Image 4: 5 fmol; Image 5: 3 fmol ; Image 6 : 
2 fmol ; Image 7 : 1 fmol ; Image 8: 0 fmol. (Detection conditions: 15 sec exposure, 2×2 
binning, 2X lens) 
 
 
 
5.2.2 Combination of Specificity and Sensitivity in DNA Detection  
In this experiment, four different probes were spotted on the chip to show the specificity, 
and the target DNA (24mer-1) was applied to specifically bind to 15mer. The absolute 
quantity of the target DNA was at the detection limit (2 fmol). The results showed highly 
specific binding as well as the successful detection at a very low concentration.  
 
Figure 11: Combination of specificity and sensitivity experiments. Image A: 5XSSC 
buffer, Image B: Bird flu DNA-RNA-DNA chimeric probe; Image C: 26mer-P; Image D: 
15mer. Absolute quantity of the target DNA (24mer-1) is 2 fmol. (Detection conditions: 5 
sec exposure, 2×2 binning, 2X lens) 
 
 
5.3 Conclusion 
The results showed that the probes and target DNA can hybridize selectively even with the 
absolute quantity of the target DNA at the detection limit. Therefore, this DNA 
chemiluminescent detection method is highly specific and also, sensitive to detect at the 
femtomole level.   
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6 DNA HYBRIDIZATION KINETICS 
6.1 Introduction 
DNA hybridization kinetic experiments are designed to obtain the measurements of the signals’ 
average intensity at a given time of hybridization between the target and probe. It is important to 
understand the kinetics of hybridization because in DNA microarray techniques, hybridization 
step is normally the rate- limiting step, 
34, 35
  and it takes a long period to hybridize the two DNA 
strands. It is also known that short DNA strands can hybridize quicker than long DNA strands. 
36, 
37
 Therefore, it is expected that the signal intensity that resulted from the hybridization of the two 
short DNA strands (15mer and 24mer-1) used in this study, will reach the plateau at a short 
hybridization time. However, hybridization temperature is kept constant at all time to study 
mainly two variables: signal intensity and hybridization time. In this experiment, probe DNA 
(15mer) is immobilized on the chip and the target DNA (Biotin-24mer-1), which was newly 
synthesized particularly for this hybridization kinetics, was applied on the chip. Once the target 
DNA is applied on the chip, the two DNA strands are allowed to hybridize for various time 
points: 0- 40 min. Biotin-24mer-1 is labeled with biotin at the 5’ end of the DNA strand. In other 
words, after hybridization occurs at a certain time point, biotin will then bind directly to Poly-
HRP streptavidin, which, in turn, will react with the substrate. To be exact, in this process, 
Klenow extension and the use of biotinylated-dNTPs are eliminated. The chemiluminescent 
signal is then detected using a microscope with a CCD camera.  
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6.2 Results 
6.2.1 DNA Hybridization Kinetics Curve 
Shown in Figure 12 are the results obtained from the DNA hybridization kinetics 
experiments. The best fit curve was generated using SigmaPlot 11.0 (Systat Software, 
Inc. SigmaPlot for Windows) to represent the data that was obtained from the 
experiments. The graph showed that the intensities reached the plateau around 9-11 
min.  
 
Hybridization Time (min)
0 5 10 15 20 25 30 35 40 45
A
v
er
ag
e 
S
ig
n
al
 I
n
te
n
si
ty
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
 
Figure 12: DNA hybridization kinetics of the interaction of the target DNA (Biotin-
24mer-1: 5’-biotin-ATGTGGATTGGCGATAAAAAACAA-3’) and the probe DNA 
(15mer: 5’-NH2-TTGTTTTTTATCGCC-3’). 
 
 
6.3 Conclusion 
According to the results, it is observed that the target DNA (Biotin-24mer-1) hybridizes 
relatively fast with the probe DNA (15mer) that is immobilized on the chip. In other words, this 
DNA detection method is a rapid method to detect pathogenic DNA. 
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7 DETECTION OF GENOMIC DNA SAMPLES 
7.1 Introduction 
In recent years, there have been illnesses caused by food infections by Esherichia coli and flu 
outbreaks occurring including Swine Flu, Avian Influenza and seasonal flu. These illnesses and 
flu outbreaks are easily spread from one continent to another because of the ease of traveling and 
the difficulty of containing the disease due to inefficient disease detection methods. Thus, it is 
necessary to be able to detect diseases rapidly on-site to prevent from spreading. 
Moreover, patients diagnose with diseases, such as cancer, are increasing as well. Capability to 
detect such diseases at early stage is essential.  Detection is available through microarray 
technology and PCR techniques. 
1, 9, 13, 14
 However, these techniques require a long processing 
time and are difficult to perform. In this study, a novel method to detect the pathogenic DNA is 
established. Instead of using longer oligonucleotides or dsDNA that needs denaturing after it is 
immobilized on the chip, this study uses the short and synthesized single-stranded DNA. In 
addition, not only the synthesized DNA, but also, the E. coli genomic DNA can be detected 
using this detection method. This detection is important because the potential to detect genomic 
DNA means that this chemiluminescent detection method is indeed useful in real life 
applications. Furthermore, this study eliminates reverse transcription, fluorescent labeling and 
the use of antibodies. Thus, it is an efficient and easy method to detect pathogenic DNA and 
could be useful for many applications. 
38
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7.2 Results and Discussion       
7.2.1 Detection of the E. coli K-12 Strain Genomic DNA 
To determine the detection limit of the E. coli K-12 Strain Genomic Target DNA, 15 mer 
was printed on the chip, and the E. coli genomic target sample (10- 5 µg)  was applied on 
the chip. 
According to the results, it was determined that 5 µg was the detection limit for E. coli K-
12 genomic DNA. In Figure 13, these results are shown. 24mer-1 (10 fmol) was used as a 
positive control and RNase-free water was used as a negative control. In between the two 
controls are the genomic samples with the absolute quantities of 10, 5, and 3 µg (Figure 
13: Image 2, 3, and 4). 
 
Figure 13: Detection limit of the E. coli K-12 strain using chemiluminescent detection 
method. Image 1: 10 fmol 24mer-1; Image 2: 10 µg E. coli genomic DNA; Image 3: 5 µg 
E. coli genomic DNA; Image 4: 3 µg E. coli genomic DNA; Image 5: RNase-free water. 
(Detection conditions: 15 sec exposure, 2×2 binning, 2X lens) 
 
   
7.3 Conclusion  
The E. coli genomic DNA was successfully detected using the DNA chemiluminescent detection 
method. In conclusion, this study simplifies the pathogenic and genomic DNA detection and is 
cost-effective and rapid. Thus, it will be useful for many applications in real life.  
1 2 
75 µ 
3 4 5 
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8 Doping of Genomic DNA with Synthesized Target DNA 
8.1 Introduction 
Synthesized target DNA (24mer-1) is a short oligonucleotide sequence from lacZ gene of 
Escherichia coli. To observe how the presence of the genomic DNA in the chemical 
environment during the hybridization of 24mer-1 to its complementary probe DNA (15mer) 
affects the detection, 24mer-1 is doped with the genomic DNA of Escherichia coli K-12 strain. 
The genomic DNA must be denatured first to participate in the hybridization process. Although 
both 24mer-1 and the genomic DNA have sequences complementary to 15mer, the 
chemiluminescent signal should be observed mainly from 24mer-1. This is due to the fact that 
the detection limit for E. coli genomic DNA using this DNA detection method is 5 µg. Thus, it is 
expected that using the absolute quantity lower than its detection limit of E. coli genomic DNA 
should not interfere with the detection of 24mer-1. In addition, a relatively strong signal should 
be observed mainly from the synthesized target DNA (24mer-1).  
   
8.2 Results and Discussion 
8.2.1 Doping of E. coli Genomic DNA with 24mer-1      
The detection limit of the hybridization between the denatured, genomic DNA of 
Escherichia coli K-12 strain and 15mer was previously observed to be 5 µg. Thus, the 
absolute quantity of 0.5 µg E. coli genomic DNA was used for the doping experiments. 
The signal was observed from doping 0.5 µg E. coli genomic DNA with 24mer-1. This 
signal was produced from the hybridization of 24mer-1 to 15mer since the absolute 
quantity of the E. coli genomic DNA used in the doping experiments was lower than its 
detection limit.  Figure 14 shows the detailed results of the doping experiments in which 
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0.5 µg E. coli genomic DNA was doped with various absolute quantities of 24mer-1 (10, 
5, and 2 fmol). To serve as the negative control, 0.5 µg E. coli genomic DNA (Image G) 
and RNase-free water (Image H) were used. Since the detection limit of E. coli genomic 
DNA was 5 µg, the absolute quantity of 0.5 µg E. coli genomic DNA alone did not 
produce a detectable signal (Image G).    
 
Figure 14: Doping of E. coli genomic DNA with 24mer-1. Image A: 0.5 µg E. coli 
genomic DNA and 10 fmol 24mer-1; Image B: 10 fmol 24mer-1; Image C: 0.5 µg E. coli 
genomic DNA and 5 fmol 24mer-1; Image D: 5 fmol 24mer-1; Image E: 0.5 µg E. coli 
genomic DNA and 2 fmol 24mer-1; Image F: 2 fmol 24mer-1; Image G: 0.5 µg E. coli 
genomic DNA; Image H: RNase-free water. (Detection conditions: 5 sec exposure, 2×2 
binning, 2X lens) 
      
8.3 Conclusion   
As expected, doping of 24mer-1 with 0.5 µg E. coli genomic DNA produced a strong signal. 
Even at an absolute quantity lower than that of the detection limit of the E. coli genomic DNA, 
the signal was observed when 24mer-1 was present in the hybridization process. This shows that 
the presence of E. coli genomic DNA in the hybridization environment does not interfere with 
the hybridization of 24mer-1 to 15mer. 
A 
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